An interventional study of MMT provider dosage training and targeted counseling in HIV, Hepatitis C and Syphilis, sponsored by Centers for Disease Control and Prevention. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-22.
Sponsored by Centers for Disease Control and Prevention · Not applicable, Interventional, and Health services research
The primary goal of this PHE is to determine the effectiveness of a tailored education program for MMT service providers. It was to be evaluated through methadone dose levels prescribed to new patients after training completion. The effects of methadone dose, with and without the inclusion of additional counseling services, would be measured through MMT retention and illicit opioid use.
Methadone treatment has became one of main actions taken in China to control the spread of HIV among drug users. However，the average methadone dose used is relatively low. An intensive methadone maintenance treatment (MMT) provider training on methadone dosage may be effective in increasing the methadone dose levels prescribed to new patients. The study will evaluate the effectiveness of a tailored education program for MMT service providers using subsequent methadone dose prescribed to new patients. The effects of methadone dose, with and without the inclusion of additional psychosocial services, will then be measured through MMT retention and illicit opioid use.
2,356 studies on the registry are indexed under Hepatitis C; 101 are open to participants now.
This study's enrollment of 4,258 is above the median of 79 across 1,660 interventional studies indexed under Hepatitis C.
Browse Hepatitis C studies →Centers for Disease Control and Prevention is the lead sponsor of 275 studies on the registry; 2 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 8 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Using currently practiced methadone dosage prescription methods
Other: national guidelines
Intensive health care provider training on prescribing methadone dosage based on national guidelines
Behavioral: MMT provider dosage training · Other: national guidelines
Intensive health care provider training on prescribing methadone dosage, plus providing on-site psychosocial counseling services and peer support to clients .
Behavioral: MMT provider dosage training · Behavioral: targeted counseling · Other: national guidelines
Training on methadone dosing provided to health care providers working in methadone maintenance clinics
Also known as: training
targeted counseling provided to methadone maintenance clinic attendees
Also known as: counseling
Provided a hard copy of the existing national guidelines for methadone dosing
Also known as: dosing guidelines
MMT retention rate
% of patients retained at the end of the year after Methadone maintenance treatment
Time frame: 12 months
Illicit opioid use rate
by urinalysis and self-report
Time frame: 12 months
HIV, HCV, syphilis and HSV-2 infection seroconversion rate
Patients who were negative converted to being seropositive
Time frame: 12 months
High risk needle practice
Shared needles used for drug injections without cleaning procedures involved
Time frame: 12 months
High risk sexual practice
Sex without condoms and also with multiple partners
Time frame: 12 months
Quality of life（WHO Quality of Life -BREF）
Scale of quality of life by WHO
Time frame: 12 months
All-cause mortality
Patients die by all causes during the program
Time frame: 12 months
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centers for Disease Control and Prevention →